2012, Number 6.II
<< Back Next >>
Rev Invest Clin 2012; 64 (6.II)
Type 2 diabetes mellitus as a prognostic factor in patients with aneurysm clipping after subarachnoid hemorrhage
Sáenz-Farret M, Salinas-Martínez AM, Macías-García MT, García-Valdez HA
Language: Spanish
References: 35
Page: 596-603
PDF size: 255.62 Kb.
ABSTRACT
Objective. To evaluate if type 2 diabetes mellitus (DM) constitutes a prognostic factor for death and severe disability in patients with aneurysm clipping after subarachnoid hemorrhage (ASH), in an Intensive Care Unit (ICU).
Material and methods. This is a cohort study in patients who were admitted to the ICU between December-2009 and June-2010; 20 with DM (exposed group) and 40 without DM (non-exposed group). Mortality was quantified during ICU stay. At ICU discharge, severe disability was measured through the Glasgow Outcome Scale (category 2); and Glasgow Coma Scale was used to estimate the difference in consciousness level between ICU arrival and discharge. Descriptive statistics and Kaplan Meier survival curves were performed.
Results. Mean age was similar between groups (55.8 ± 11 and 55.6 ± 15 years, respectively, p = 0.40). A vegetative state was present in one patient without DM. The Glasgow Coma Scale score at ICU entry was 14.1 ± 1.4 and at discharge, 12.0 ± 3.6 in the exposed group (p = 0.01); and 13.9 ± 2.0
vs. 13.5 ± 2.6, in the non-exposed group, respectively (p = 0.45). There were 3 deaths in patients with DM and 5, in patients without DM (p › 0.05); survival time was 12 (95%CI 7, 16) and 10 days (95%CI 7, 13), respectively. Mean glucose remained higher in patients who died at the ICU (p ‹ 0.001). Hydrocephaly was present in 6 exposed patients and 2, non-exposed (p = 0.007). Additionally, 7 and 5 with and without DM, respectively registered a positive blood culture (p = 0.04).
Conclusions. DM was not associated with higher mortality in ICU patients, but hyperglycemia was; thus, it is essential that the intensive care provider watches closely the glycemic control.
REFERENCES
Wilson SR, Hirsch NP, Appleby I. Management of subarachnoid haemorrhage in a non-neurosurgical centre. Anaesthesia 2005; 60: 470-85.
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.
Feigin VL. Stroke epidemiology in the developing world. Lancet 2005; 365 (9478): 2160-1f.
Rosengart AJ, Shultheiss KE, Tolentino J, Mcdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007; 38: 2315-21.
Juvela S, Siironen J, Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005; 102: 998-1003.
Ruiz-Sandoval JL, Cantú C, Chiquete E, León-Jiménez C, Arauz A, Murillo-Bonilla LM, et al. Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASC study. J Stroke Cerebrovasc Dis 2009; 18: 48-55.
Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 2005; 28: 355-9.
Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicolls MG. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol 1990; 47: 1174-7.
Graham BB, Keniston A, Gagic O, Trillo Alvarez CA, Medvedev S, Douglas IS. Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med 2010; 38: 295-6.
Bochicchio GV, Joshi M, Bochicchio K, Shih D, Meyer W, Scalea TM. Incidence and impact of risk factors in critically ill trauma patients. World J Surg 2006; 30: 114-18.
Arboix A, Oliveres M, Massons J, Targa C, García-Eroless L. Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorraghe. Diabetes Care 2000; 23: 1527-32.
Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICESUGAR study data. CMAJ 2009; 180: 821-7.
Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005; 33: 2772-7.
Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M. Blood glucose concentration and outcome of critical illness: The impact of diabetes. Crit Care Med 2008; 36: 2249-55.
Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 2005; 80: 1558-67.
Christiansen C, Toft P, Jørgensen HS, Andersen SK, Tønnesen E. Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 2004; 30: 1685-88.
Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: Six and onehalf years experience at a university affiliated community hospital. Seminars in thoracic and cardiovascular. Surgery 2006; 18: 317-25.
Arboix A. Stroke prognosis in diabetes mellitus: New insights but questions remain. Expert Rev Cardiovasc Ther 2009; 7: 1181-5.
Teasdale G, Jennet B. Assessment of impaired consciousness and coma: a practical scale. Lancet 1974; 2: 81-4.
Jannett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975; 1: 573-85.
Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1-9.
Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracraneal aneurisma. J Neurosurg 1974; 21: 79-89.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
Heron MP, Hoyert DL, Murphy SL, Xu JQ, Kochanek KD, Tejada- Vera B. Deaths: Final data for 2006, National Vital Statistics Reports; 57(14). Hyattsville, MD: National Center for Health Statistics. 2009.
Bhalla A, Sankaralingam S, Tilling K, Swaminathan R, Wolfe C, Rudd A. Effect of acute glycaemic index on clinical outcome after acute stroke. Cerebrovasc Dis 2002; 13: 95-101.
Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59(1): 67-71.
Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med 2004; 32: 832-8.
McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007; 107: 1080-5.
Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: Data from the European BIOMED stroke project. Stroke 2003; 34: 688-94.
Halkos ME, Lattouf OM, Puskas JD, Kilgo P, Cooper WA, Morris CD, et al Elevated preoperative hemoglobin A1c is associated with reduced long-term survival alter coronary artery bypass surgery. Ann Thorac Surg 2008; 86: 1431-7.
Kassell NF, Torner JC, Haley EC. The international co-operative study on the timing of aneurysm surgery. Part 1: over-all management results. J Neurosurg 1990; 73: 18-36.
Cargill HA. Aneurysmal subarachnoid haemorrhage. Neurology 2010; 74: 1486-7.
Saposnik G, Baibergenova A, Bayer N, Hachinski V. Weekends: A dangerous time for having a stroke. Stroke 2007; 38: 1211-15.
Hemphill JC, White DB. Clinical Nihilism in Neuroemergencies. Emerg Med Clin N Am 2009; 27: 27-37.
Salary M, Quigley MR, Wilberger JE. Relation among aneurysm size, amount of subarachnoid blood, and clinical outcome. J Neurosurg 2007; 107: 13-17.